Rösch, R. M., Schnorbach, J., Klotz, L. V., Griffo, R., Thomas, M., Stenzinger, A., . . . Eichhorn, F. (2025). NeoTRACK trial: Neoadjuvant TiRagolumab, Atezolizumab and Chemotherapy : dissection of IO- efficacy in NSCLC by longitudinal tracKing : protocol of a non-randomised, open-label, single-arm, phase II study. BMJ open, 15(3), . https://doi.org/10.1136/bmjopen-2024-096617
Chicago-Zitierstil (17. Ausg.)Rösch, Romina M., et al. "NeoTRACK Trial: Neoadjuvant TiRagolumab, Atezolizumab and Chemotherapy : Dissection of IO- Efficacy in NSCLC by Longitudinal TracKing : Protocol of a Non-randomised, Open-label, Single-arm, Phase II Study." BMJ Open 15, no. 3 (2025). https://doi.org/10.1136/bmjopen-2024-096617.
MLA-Zitierstil (9. Ausg.)Rösch, Romina M., et al. "NeoTRACK Trial: Neoadjuvant TiRagolumab, Atezolizumab and Chemotherapy : Dissection of IO- Efficacy in NSCLC by Longitudinal TracKing : Protocol of a Non-randomised, Open-label, Single-arm, Phase II Study." BMJ Open, vol. 15, no. 3, 2025, https://doi.org/10.1136/bmjopen-2024-096617.